Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Douglas W. Shevlin"'
Autor:
Gaurav Sangwan, Donald R. Graham, Jerry Lawhorn, Lavanya Kolluri, Robert Vautrain, Cheryl Drake, Ashley B. Moja, Charles D. Callahan, Steven J. Verhulst, Lauren B. Moja, Matthew M. Ertmoed, Douglas W. Shevlin, Joan Barenfanger, Ryan Peterson
Publikováno v:
American Journal of Clinical Pathology. 130:870-876
Gram stains of positive blood cultures are the most important factor influencing appropriate therapy. The sooner appropriate therapy is initiated, the better. Therefore, it is reasonable to expect that the sooner Gram stains are performed, the better
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b31afe1b37279427cef2dca248e230b
https://doi.org/10.1309/ajcpvmdqu2zjdpbl
https://doi.org/10.1309/ajcpvmdqu2zjdpbl
Publikováno v:
Annals of Diagnostic Pathology. 1:82-90
Postoperative granulomas of the male urogenital tract are a well-recognized phenomenon. Similar granulomas have also been described in the uterine cervix, fallopian tube, and other sites after various procedures, as well as in the endometrium after e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c720b06242b7a64081ba9dea55345650
https://doi.org/10.1016/s1092-9134(97)80012-3
https://doi.org/10.1016/s1092-9134(97)80012-3
Autor:
Doris J. Tribune, Paul J. Goodfellow, William S. Tung, Douglas W. Shevlin, Zahid Kaleem, Samuel A. Wells
Publikováno v:
Genes, Chromosomes and Cancer. 19:43-51
Numerous studies aimed at the identification of chromosomal regions that are frequently deleted in specific tumor types have pointed to the location and involvement of specific tumor suppressor genes. Previous studies of loss of heterozygosity (LOH)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33112ce5136fb3ad00a78e8556faa6e5
https://doi.org/10.1002/(sici)1098-2264(199705)19:1<43::aid-gcc7>3.0.co
https://doi.org/10.1002/(sici)1098-2264(199705)19:1<43::aid-gcc7>3.0.co
Autor:
Samuel A. Wells, William S. Tung, Detlef Bartsch, Jeffrey A. Norton, Douglas W. Shevlin, Paul J. Goodfellow
Publikováno v:
Molecular Carcinogenesis. 15:5-10
We examined the frequency of cyclin-dependent kinase (CDK) N2 alterations in differentiated and anaplastic thyroid cancers to assess the involvement of CDKN2 in the development of these cancers. The CDKN2 gene, which encodes the cell-cycle regulator
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc6c11cfad4e582953eebc0c69706c8e
https://doi.org/10.1002/(sici)1098-2744(199601)15:1<5::aid-mc2>3.0.co
https://doi.org/10.1002/(sici)1098-2744(199601)15:1<5::aid-mc2>3.0.co
Autor:
Douglas W. Shevlin, Samuel A. Wells, O Kisker, Paul J. Goodfellow, William S. Tung, Detlef Bartsch
Publikováno v:
Genes, Chromosomes and Cancer. 14:189-195
The gene encoding the cell-cycle regulatory protein p16, CDKN2, is localized on chromosome band 9p21. CDKN2 is frequently deleted or mutated in a variety of tumor cell lines, including pancreatic cancer cell lines and xenografts, as well as in some p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::567968caf04223254becd51804185972
https://doi.org/10.1002/gcc.2870140306
https://doi.org/10.1002/gcc.2870140306
Autor:
Douglas W. Shevlin, Cheryl A. Brewer
Publikováno v:
Obstetrics and gynecology. 92(4 Pt 2)
Background: Chemotherapy for steroid tumors of unspecified type has met with limited success and the overall prognosis has been poor. Case: A patient with a virilizing steroid tumor, otherwise unspecified, with demonstrated progressive disease after
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::676310c1b811d0bbedc940df402c0a59
https://pubmed.ncbi.nlm.nih.gov/9764654
https://pubmed.ncbi.nlm.nih.gov/9764654
Autor:
Douglas W. Shevlin, Detlef Bartsch, Paul J. Goodfellow, Mark P. Callery, Samuel A. Wells, Jeffrey A. Norton
Publikováno v:
Journal of the National Cancer Institute. 88(10)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ceb34875ba054b07fbdb8fb74942554
https://pubmed.ncbi.nlm.nih.gov/8627645
https://pubmed.ncbi.nlm.nih.gov/8627645
Autor:
Samuel A. Wells, Douglas W. Shevlin, Mark P. Callery, Matthias Rothmund, Detlef Bartsch, Paul J. Goodfellow
Publikováno v:
Chirurgisches Forum ’96 fur experimentelle und klinische Forschung ISBN: 9783540609056
Das Tumorsuppressorgen CDKN2 (MTS1, p16INK4a) scheint eine zentrale Rolle in der Tumorgenese des duktalen Pankreaskarzinoms zu spielen. CDKN2 ist mutiert oder deletiert in einer grosen Anzahl von Pankreaskarzinomzellinien, -xenografts und primaren Ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5314f8c4d41058554dd0a801d35bc56a
https://doi.org/10.1007/978-3-642-80138-9_38
https://doi.org/10.1007/978-3-642-80138-9_38
Publikováno v:
American Journal of Clinical Pathology. 110:264.2-265
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e4723c08712b25fabb31092d4072791e
https://doi.org/10.1093/ajcp/110.2.264a
https://doi.org/10.1093/ajcp/110.2.264a